HIGHFDA DRUG

Amneal Chlorpromazine Hydrochloride Recall 2025: 14,923 Bottles Over Packaging Contamination

Amneal Pharmaceuticals recalled 14,923 bottles of Chlorpromazine Hydrochloride 100 mg tablets sold nationwide in the United States. A packaging coil used in the product’s packaging was found to contain a microorganism. No microorganism was detected on any tablets. Stop using the product and contact Amneal or your healthcare provider for guidance.

Official notice

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DRUG
Recall date
August 18, 2025
Status
ACTIVE
Severity
7/10

Quick Facts at a Glance

Recall Date
August 18, 2025
Hazard Level
HIGH
Brands
Chlorpromazine Hydrochloride, Amneal Pharmaceuticals
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Drug Safety; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
Chlorpromazine Hydrochloride, Amneal Pharmaceuticals
Product type
Chlorpromazine Hydrochloride Tablets
Model numbers
AM240334, AM240335, AM241031
UPC codes
69238-1054, 69238-1056, 69238-1058, 69238-1060, 69238-1062, 69238-1054-1, 69238-1056-1, 69238-1058-1 +2 more
Sizes
100-count bottles
Sold at
Multiple Retailers
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    August 18, 2025

  2. Reported by FDA DRUG

    September 10, 2025

  3. RecallRadar source check

    April 18, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

Presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging was detected with presence of a micro-organism. No micro-organism was detected on any tablets.

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact Amneal Pharmaceuticals, LLC or your healthcare provider for guidance. Notification method: Letter

About This Product

Chlorpromazine hydrochloride is an antipsychotic medication used to treat certain psychiatric conditions. It is distributed in the United States through a network of healthcare providers.

Industry Context

This recall is not described as part of a broader industry pattern.

Real-World Impact

Consumers may need to switch medications under supervision. There is no reported contamination of tablets, but packaging contamination could pose health risks.

Practical Guidance

How to identify if yours is affected

  1. Check if your bottle bears NDC 69238-1060-1.
  2. Look for lot numbers AM240334, AM240335, AM241031 on the bottle/box.
  3. Confirm packaging uses auxiliary polyester coil as described in the recall.

Where to find product info

NDC and lot codes on label; recall notice provides official details.

What timeline to expect

Recall processing timelines are not specified in the notice.

If the manufacturer is unresponsive

  • Document all communications with the company and healthcare provider.
  • Escalate to FDA recall contacts if no response is received within a reasonable timeframe.
  • Consider filing a report with the FDA if you suspect unsafe conditions.

How to prevent similar issues

  • If purchasing prescription meds, verify packaging quality and lot numbers.
  • Consult your healthcare provider for approved alternatives if you must switch meds.
  • Maintain a record of recall notices and medication changes.

Documentation advice

Keep bottle, packaging, and recall notices. Save correspondence with the company and healthcare providers.

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

NDC: 69238-1060-1. Sold nationwide in the USA. 14,923 bottles recalled. Lot numbers AM240334, AM240335, AM241031. 100 mg tablets in 100-count bottles. Manufactured by Amneal Pharmaceuticals Pvt. Ltd., Ahmedabad, India. Distributed by Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807. Classification: Class II. Product type: Oral solid dosage unit (Tablets).

Reported Incidents

No injuries or incidents have been reported.

Key Facts

  • 14,923 bottles recalled nationwide
  • Lot numbers AM240334, AM240335, AM241031
  • Manufactured in India; distributed by US-based affiliate

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
7/ 10
Affected Groups
GENERAL
Injury Types
POISONING

Product Classification

Product Details

Model Numbers
AM240334
AM240335
AM241031
UPC Codes
69238-1054
69238-1056
69238-1058
+7 more
Affected States
ALL
Report Date
September 10, 2025
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls